Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 12:33 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 697–720 of 4,439 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Reports Clear all

Conditions: Crohn's Disease
Interventions: Vedolizumab (VDZ), Ustekinumab (UST), Risankizumab (RISA), Guselkumab (GUS), Mirikizumab (MIR); Drug
Lead sponsor: Alimentiv Inc.; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 11
States / cities: Sun City, Arizona • Evanston, Illinois • Iowa City, Iowa + 8 more

Conditions: Antibiotic Side Effect, Behavioral Changes
Interventions: CDC Core Elements of Outpatient Stewardship; Behavioral
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: Not listed
Enrollment: 700,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Murray, Utah

Conditions: Opioid Use Disorder, Chronic Pain
Interventions: Acceptance and Commitment Therapy + Mindfulness Based Relapse Prevention (ACT + MBRP), Enhance Usual Care (EUC); Behavioral
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Albuquerque, New Mexico

Conditions: Overdose
Interventions: Brief youth overdose prevention education, Usual Standard of Care; Behavioral · Other
Lead sponsor: Boston Medical Center; Other
Eligibility: 13 Years and older
Enrollment: 648 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Digestive Disease, Gut Health
Interventions: Probiotic, Placebo; Dietary Supplement · Other
Lead sponsor: Synbiotic Health; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 92 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Migraine
Interventions: Thermal stimuli, Pressure stimuli, Pain ratings, Pressure pain thresholds (PPT), Conditioned pain modulation (CPM) response, PedMIDAS (Pediatric Migraine Disability Assessment), Hormonal assessment, Pubertal status; Device · Behavioral · Diagnostic Test + 1 more
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 11 Years to 15 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: BPH, Lower Urinary Tract Symptoms
Interventions: Telephone Interview, Questionnaires over the span of 24 months; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 100 Years · Male only
Enrollment: 252 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Bipolar Disorder
Interventions: Adjunctive Yoga, Enhanced Treatment as Usual; Behavioral
Lead sponsor: Brown University; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Childhood Obesity, Cardiovascular Disease Prevention
Interventions: In-home Visits and Food Preparation Activities, Ecological Momentary Intervention, Feedback on Video-recorded Family Meals, Maintenance; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 5 Years to 10 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2028
U.S. locations: 2
States / cities: Aurora, Colorado • Minneapolis, Minnesota

Conditions: Medication Compliance
Interventions: Telehealth Calls; Other
Lead sponsor: W.G. Bill Hefner Medical Center; Federal
Eligibility: Not listed
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Salisbury, North Carolina

Conditions: Eye Strain
Interventions: Total 30 Contact Lens; Device
Lead sponsor: Tauber Eye Center; Other
Eligibility: 18 Years to 40 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Cancer
Interventions: Embodied Conversational Agent, REDCap Survey; Behavioral
Lead sponsor: Tufts Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Colorectal Carcinoma
Interventions: NPT-PLA, Usual Quality Improvement; Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 45 Years to 75 Years
Enrollment: 2,200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Knee Osteoarthritis
Interventions: Physical Therapy, Platelet-Rich Plasma Injection, Photobiomodulation Therapy; Other · Biological · Device
Lead sponsor: Musculoskeletal Injury Rehabilitation Research for Operational Readiness; Federal
Eligibility: 18 Years to 64 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Tacoma, Washington

Conditions: Bacteremia, Fungemia, Bloodstream Infection
Interventions: FilmArray testing, Antimicrobial Stewardship, Bacterial culture, Susceptibility testing; Device · Behavioral · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: Up to 99 Years
Enrollment: 743 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Communication, Pain
Interventions: InfoViz; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 13 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 2
States / cities: Madison, Wisconsin

Conditions: Head and Neck Cancer
Interventions: Electronic Patient Visit Assessment (ePVA); Behavioral
Lead sponsor: New York University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Amputation
Interventions: Primary TMR, Secondary TMR; Procedure
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Cancer Patients and Physical Activity
Interventions: Questionnaires; Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Gastroesophageal Reflux Disease (GERD)
Interventions: NDO Full-thickness Plicator; Device
Lead sponsor: NDO Surgical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 6
States / cities: Los Angeles, California • Boston, Massachusetts • Rochester, Minnesota + 3 more

Conditions: Asthma
Interventions: Benralizumab-exposure, Exposure to other asthma medications; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years · Female only
Enrollment: 299 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: San Diego, California

Conditions: Multiple Sclerosis
Interventions: Not listed
Lead sponsor: Biogen; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 383 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2017
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Major Depression, Dysthymia, Depressive Symptoms
Interventions: Teen Depression Module used for care; Behavioral
Lead sponsor: Total Child Health, Inc.; Industry
Eligibility: 12 Years to 99 Years
Enrollment: 580 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Asthma, Quality of Life, Children
Interventions: Asthma Education Sessions, Asthma Health Assessment via Telemonitoring, Provider Treatment Prompt, School Absenteeism, Prescription Filling Profile; Other
Lead sponsor: Arkansas Children's Hospital Research Institute; Other
Eligibility: 7 Years to 14 Years
Enrollment: 823 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Little Rock, Arkansas

Search by objective public record fields.

VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study

Improving Antibiotic Use in Urgent Care Facilities

Healing Opioid Misuse and Pain Through Engagement (HOPE) Trial

A Universal Primary Care Based Intervention to Reduce Youth Overdose Risk Aim 3

Impact of B. Adolescentis iVS-1 Probiotic on Gastrointestinal Outcomes

Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine

HoLEP Sexual Survivorship

Pilot Study of Adjunctive Yoga for Bipolar Depression

Family Matters Intervention

Trial of Oral Lenalidomide Stewardship Program for Veterans

To Evaluate the Performance of Total 30 (Lehifilcon A) Contact Lenses in Patients Using Digital Devices for Greater Than 8 Hours Per Day 5 Days Per Week Based on Subjective Reported Data.

Improving PRO for Patients With Cancer Using ECAs and Data Visualization

Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)

Investigating Orthobiologics After PRP and Photobiomodulation for Knee Osteoarthritis

Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures

Visualizations to Improve Pain Communication Between Patients, Interpreters, and Providers

A Feasibility Study to Evaluate The Effect of the Electronic Patient Visit Assessment On Pain and Quality of Life for Patients With Head and Neck Cancer (HNC)

Patient Reported Outcomes Following Targeted Muscle Reinnervation

Barriers Affecting Physical Activity

Endoscopic Full-Thickness Plication for the Treatment of GERD: Long-Term Multicenter Results

Benralizumab Pregnancy Exposure Study

Controlled High Risk AVONEX® Multiple Sclerosis Prevention Study In Ongoing Neurological Surveillance

Online System for Identifying and Addressing Teen Depression in Primary Care

Reducing Asthma Disparities Through School-Based Telemedicine for Rural Children